Source: Citybizlist

Aerpio: Aadi Bioscience Closes Merger with Aerpio Pharmaceuticals

Shares of Aadi to commence trading on the Nasdaq Capital Market on August 27, 2021 under ticker symbol "AADI" Concurrent... Read MoreThe post Aadi Bioscience Closes Merger with Aerpio Pharmaceuticals appeared first on citybiz.

Read full article »

Aerpio's Competitors | Aerpio's News | Aerpio's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

President & CEO

Joseph Gardner

CEO Approval Rating

84/100

Aerpio is an Ohio-based biopharmaceutical company that develops and commercializes Tie2-based protein therapeutics for the treatment of ocular diseases.